2335 Analysis of activity, efficacy and safety of first line Nab Paclitaxel (Nab-P) and Gemcitabine (G) in advanced pancreatic cancer (APDAC) frail and elderly patients (pts). (September 2015) - Giordano, G.; De Vita, F.; Melisi, D.; Vaccaro, V.; Zaniboni, A.; Zagonel, V.; Vasile, E.; Passardi, A.; Leo, L.; Ventriglia, J.; Marciano, R.; Russano, M.; et al.